Anthos Therapeutics’ Post

View organization page for Anthos Therapeutics, graphic

3,949 followers

The future is #FactorXI. Watch this video featuring Dr. Christian Ruff, where he explains the overwhelmingly positive significance of the AZALEA-TIMI 71 results. He discusses the promise of abelacimab, a novel monoclonal antibody and dual-acting Factor XI/XIa inhibitor, and potential future treatment options for patients with #afib. #atrialfibrillation #afibawareness #strokeawareness #thrombosis #hemostasis #anticoagulant #anticoagulation 

Lynell D'Sylva

Clinical Trial Ambassadors and Community Clinical Trial Liaisons, Sr. Director North America |Pharmaceutical Leadership

10mo

This is an exciting time for the anticoagulants and certainly promising for those still deemed unsuitable for current standard of care.

To view or add a comment, sign in

Explore topics